Correlation Between Collegium Pharmaceutical and Dr Reddys

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Collegium Pharmaceutical and Dr Reddys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collegium Pharmaceutical and Dr Reddys into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Collegium Pharmaceutical and Dr Reddys Laboratories, you can compare the effects of market volatilities on Collegium Pharmaceutical and Dr Reddys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collegium Pharmaceutical with a short position of Dr Reddys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collegium Pharmaceutical and Dr Reddys.

Diversification Opportunities for Collegium Pharmaceutical and Dr Reddys

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Collegium and RDY is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Collegium Pharmaceutical and Dr Reddys Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dr Reddys Laboratories and Collegium Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collegium Pharmaceutical are associated (or correlated) with Dr Reddys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dr Reddys Laboratories has no effect on the direction of Collegium Pharmaceutical i.e., Collegium Pharmaceutical and Dr Reddys go up and down completely randomly.

Pair Corralation between Collegium Pharmaceutical and Dr Reddys

Given the investment horizon of 90 days Collegium Pharmaceutical is expected to under-perform the Dr Reddys. In addition to that, Collegium Pharmaceutical is 1.32 times more volatile than Dr Reddys Laboratories. It trades about -0.28 of its total potential returns per unit of risk. Dr Reddys Laboratories is currently generating about -0.18 per unit of volatility. If you would invest  1,528  in Dr Reddys Laboratories on August 26, 2024 and sell it today you would lose (108.00) from holding Dr Reddys Laboratories or give up 7.07% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Collegium Pharmaceutical  vs.  Dr Reddys Laboratories

 Performance 
       Timeline  
Collegium Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Collegium Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Dr Reddys Laboratories 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dr Reddys Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Collegium Pharmaceutical and Dr Reddys Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Collegium Pharmaceutical and Dr Reddys

The main advantage of trading using opposite Collegium Pharmaceutical and Dr Reddys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collegium Pharmaceutical position performs unexpectedly, Dr Reddys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dr Reddys will offset losses from the drop in Dr Reddys' long position.
The idea behind Collegium Pharmaceutical and Dr Reddys Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance